InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,804.00
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
59,606.75
(
2.96%
)
Post# of 30387
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bocxman

Send PM Follow Ignore
Followers 2
Posts 1054
Boards Moderated 0
Alias Born 03/03/2005

bocxman

Re: None

Tuesday, 05/16/2006 4:49:09 PM

Tuesday, May 16, 2006 4:49:09 PM

Post# of 30387
HALF_FULL: my hope has always been that we get paired up with PSA in the same way that the Gleeson Test is now. Many here seem to disagree, but to me that is clearly the logical route and I believe ABT will do that. There are two main reasons why we need to be paired with a current blockbuster test:

1) RECAF is not a standalone marker because it cannot localize cancer like PSA, etc do. I don't want to hear about the imaging application for localization...that is all B.S.

2) Marketing a "value add" to an existing test will be 10 times easier than trying to create our own market.


DISCLAIMER: NEVER ASSUME INFO ON MESSAGE BOARDS TO BE ACCURATE. ALWAYS DO YOUR OWN DUE DILIGENCE. DON'T BUY STOCK BASED ON THIS POST OR ANY OTHER POST. I OWN A LONG POSITION IN THIS STOCK AND THEREFORE I AM BIASED.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up